PASITHEA THERAPEUTICS CORP. Fair Value Adjustment of Warrants
PASITHEA THERAPEUTICS CORP. (KTTA) reported Fair Value Adjustment of Warrants of -$20.62 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$20.62K, a 344.48% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$1.54M.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$46.87K, a 166.67% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for fiscal 2025 was -$115.30K, a 248.19% decline from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for fiscal 2024 was $77.81K.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for fiscal 2023 was -$56.24K.
- PASITHEA THERAPEUTICS CORP. fair value adjustment of warrants for fiscal 2022 was -$1.85M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$20.62K 10-Q · filed 2026-08-14 | -$1.56M 10-Q · filed 2026-08-14 | -$1.56M derived: sum of 3 quarters · filed 2026-08-14 | -$1.61M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$1.54M 10-Q · filed 2026-05-15 | -$1.54M derived: sum of 2 quarters · filed 2026-05-15 | -$1.59M derived: sum of 3 quarters · filed 2026-05-15 | -$1.58M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$46.87K derived: sum of 2 quarters · filed 2026-03-30 | -$38.43K derived: sum of 3 quarters · filed 2026-08-14 | -$115.30K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | -$46.87K 10-Q · filed 2025-11-13 | -$38.43K derived: sum of 2 quarters · filed 2026-08-14 | -$115.30K 10-Q · filed 2025-11-13 | -$116.71K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $8.44K 10-Q · filed 2026-08-14 | -$68.43K 10-Q · filed 2026-08-14 | -$69.84K derived: sum of 3 quarters · filed 2026-08-14 | $469.00 derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$76.87K 10-Q · filed 2026-05-15 | -$78.27K derived: sum of 2 quarters · filed 2026-05-15 | -$7.97K derived: sum of 3 quarters · filed 2026-05-15 | $27.66K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$1.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $68.90K derived: sum of 2 quarters · filed 2026-03-30 | $104.52K derived: sum of 3 quarters · filed 2026-03-30 | $77.81K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $70.31K 10-Q · filed 2025-11-13 | $105.93K derived: sum of 2 quarters · filed 2025-11-13 | $79.21K 10-Q · filed 2025-11-13 | $134.52K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $35.62K 10-Q · filed 2025-08-14 | $8.91K 10-Q · filed 2025-08-14 | $64.21K derived: sum of 3 quarters · filed 2025-08-14 | $19.22K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$26.72K 10-Q · filed 2025-05-15 | $28.59K derived: sum of 2 quarters · filed 2025-05-15 | -$16.41K derived: sum of 3 quarters · filed 2025-05-15 | -$129.83K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $55.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $10.31K derived: sum of 2 quarters · filed 2025-03-24 | -$103.11K derived: sum of 3 quarters · filed 2025-03-24 | -$56.24K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | -$45.00K 10-Q · filed 2024-11-13 | -$158.42K derived: sum of 2 quarters · filed 2024-11-13 | -$111.55K 10-Q · filed 2024-11-13 | -$1.09M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$113.43K 10-Q · filed 2024-08-13 | -$66.56K 10-Q · filed 2024-08-13 | -$1.05M derived: sum of 3 quarters · filed 2024-08-13 | -$711.75K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $46.87K 10-Q · filed 2024-05-14 | -$933.64K derived: sum of 2 quarters · filed 2024-05-14 | -$598.32K derived: sum of 3 quarters · filed 2024-05-14 | -$1.02M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$980.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$645.19K derived: sum of 2 quarters · filed 2024-03-29 | -$1.07M derived: sum of 3 quarters · filed 2024-03-29 | -$1.85M 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $335.32K 10-Q · filed 2023-11-13 | -$86.38K derived: sum of 2 quarters · filed 2023-11-13 | -$871.68K 10-Q · filed 2023-11-13 | -$3.46M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$421.70K 10-Q · filed 2023-08-11 | -$1.21M 10-Q · filed 2023-08-11 | -$3.79M derived: sum of 3 quarters · filed 2023-08-11 | -$3.54M derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | -$785.30K 10-Q · filed 2023-05-12 | -$3.37M derived: sum of 2 quarters · filed 2023-05-12 | -$3.12M derived: sum of 3 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$2.33M derived: sum of 2 quarters · filed 2023-03-30 | -$2.33M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $252.51K 10-Q · filed 2022-11-14 | $252.00K 10-Q · filed 2021-11-18 | $252.51K 10-Q · filed 2022-11-14 | $252.00K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |